| Metric | შპს ნეოფარმი + | შპს ნეოფარმი |
|---|---|---|
| Growth | ||
| Revenue | ₾16.3m₾13.9m | ₾19.2m₾15.4m |
| Revenue growth | 17.4% | 25.0% |
| Profitability | ||
| EBITDA | -₾836k-₾1.3m | -₾498k-₾1.4m |
| EBITDA margin | -5.1%-9.0% | -2.6%-9.4% |
| Net profit | -₾873k-₾1.3m | -₾589k-₾1.5m |
| Net margin | -5.4%-9.1% | -3.1%-9.5% |
| Balance sheet | ||
| Total assets | ₾5.7m₾6.3m | ₾8.0m₾8.5m |
| Total equity | ₾14k₾887k | ₾5.1m₾6.1m |
| ROE | -6150.6%-142.2% | -11.6%-23.8% |